Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q1 2017 · 10-Q
Revenue$29.44M$29.44M+4.1% vs Q1 2016 Net Income-$30.61M-$30.61MN/M vs Q1 2016 EPS Diluted-$0.48-$0.48N/M vs Q1 2016 Operating Income-$28,820,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
Free Cash Flowderived-$27,771,000N/M Margins · derivedOperating margin-97.9%−3.2 pt vs Q1 2016
Net margin-104.0%−5.5 pt vs Q1 2016
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end